1. Açık Erişim@BUU

Browsing by Author Marcellin, P.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)
2004-10ALT flares and sustained ALT response in patients with HBeAg-negative chronic hepatitis B treated with peginterferon alfa-2a (40KD) (PEGASYS (R)), peginterferon alfa-2a (40KD) plus lamivudine or lamivudine alonePiratvisuth, T.; Marcellin, P.; Lau, G.; Bonino, F.; Farci, P.; Hadziyannis, S.; Jin, R.; Lu, Z.M.; Germanidis, G.; Yurdaydın, C.; Diago, M.; Lai, M.Y.; Button, P.; Why, R.D.; Pluck, N.; Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı.; Gürel, S.
2013-04Long term tenofovir disoproxil fumarate (tdf) therapy and the risk of hepatocellular carcinomaKim, W. R.; Berg, Thomas; Loomba, Rohit; Schall, Raul Aguilar; Dinh, Phillip; Yee, Leland J.; Martins, Eduardo B.; Flaherty, John F.; Buti, Maria; Marcellin, P.; Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı.; Gürel, Selim
2003-10A phase III, partially double-blinded study evaluating the efficacy and safety of peginterferon alfa-2a (40KD) (PEGASYS (R)) alone or in combination with lamivudine vs lamivudine in 546 patients with HBeAg-negative/anti-HBe-positive chronic hepatitis B.Marcellin, P.; Lau, G.; Bonino, F.; Farci, P.; Hadziyannis, S.; Jin, R.; Lu, Z.; Piratvisuth, T.; Germanidis, G.; Yurdaydın, C.; Diago, M.; Lai, M.; Button, P.; Pluck, N.; Uludağ Üniversitesi/Tıp Fakültesi.; Gürel, S.; AAH-5364-2019; ABI-3764-2020
2004-10Profound on-treatment viral suppression with peginterferon alfa-2a (40KD) (PEGASYS (R)) plus lamivudine combination therapy limits the development of YMDD mutations, but does not improve sustained response rates over peginterferon alfa-2a (40KD) aloneGermanidis, G.; Marcellin, P.; Lau, G.; Bonino, F.; Farci, P.; Hadziyannis, S.; Jin, R.; Yao, G.B.; Piratvisuth, T.; Yurdaydın, C.; Diago, M.; Lai, M.Y.; Popescu, M.; Pluck, N.; Uludağ Üniversitesi/Tıp Fakültesi.; Gürel, S.
Showing results 1 to 4 of 4